Other Upcoming Programs

Surviving the Doctorectomy: Charting Commercial Success with the Rise of the Hospital C-Suite Decision-Maker

October 18, 8:00 – 10:30 a.m.
Mass. Medical Society, Waltham, Mass.

While shifts have been occurring for well over a decade, it is now clear that the balance of power is sliding rapidly from clinical decision-makers to those responsible for the bottom line. All companies, from start-ups to well-established organizations, are rethinking their sales and marketing strategies to reach this challenging target audience. Join us on October 18, as a panel of your peers collaborates in real time to develop a C-suite-centric approach to positioning and selling hospital products.

Join us on October 18, from 8:00 – 10:30 a.m. at the Mass. Medical Society in Waltham, as a panel of your peers collaborates in real time to develop a C-suite-centric approach to positioning and selling hospital products.

Register here.

Sponsored by:


MedTech Investors Conference
November 1, 8:00 a.m. – 3:00 p.m.
Campus Center – UMass-Boston

Join us on November 1, from 8:00 a.m. – 3:00 p.m. at the UMass Boston Campus Center, as 18 emerging MedTech companies from the around the region make their 10-minute investor pitches for a gathering of more than 400 attendees from the financing, consulting and manufacturing sectors. This year’s presenting companies include (confirmed to date):

  • Allurion Technologies
  • Cellanyx Diagnostics
  • CSAMedical, Inc.
  • Etiometry, LLC
  • GestSure Technologies
  • Harvard Apparatus Regenerative Technology
  • InfoBionic
  • Little Sparrows Technologies
  • Metactive Medical, LLC
  • Modusci
  • MẌ Orthopedics, Corp.
  • NeuroQore, Inc.
  • NinePoint Medical
  • Opus KSD, Inc.
  • Organ Solutions
  • Respiratory Motion Inc.
  • UV Therapeutics, Inc.
  • Vittamed

This year’s agenda will also include plenary presentations on M&A activity in the region; UMass President Bob Carat on what’s happening in Life Science in the five-campus system; and updates on entrepreneurial activities in Massachusetts. The afternoon session will feature presentations by representatives from four public MedTech companies – Abiomed, Boston Scientific, Johnson & Johnson and Teijin Pharma Ltd. Throughout the day, there’ll be plenty of opportunities to network with entrepreneurs, investors and business development executives. For more information, please click here.



MedTech IGNITE Presents: User Needs & Design Inputs for Successful Product Development for Emerging MedTech Companies
November 12, 8:00 a.m. – 12:00 p.m.
Mass. Medical Society, Waltham, Mass.

Ximedica, a leading healthcare product development accelerator and Aptiv Solutions, a global medical device CRO, have joined forces to create a half-day dynamic workshop designed to educate emerging companies on how to set the stage for success. This program emphasizes ways to mitigate risk along the medical device development pathway to achieve product clearance/approvals in the US, EU and other identified markets outside the US. It’s purpose is to educate medical device research, design and development teams not only on how to successfully bring a medical device to market, but also to ensure continued product success following launch.

Register here.

Sponsored by:


FDA Update – in conjunction with
ASQ – New England Biomedical Discussion Group & RAPS, Boston Chapter

December 9, 8:00 a.m. – 3:00 p.m.
Mass. Medical Society, Waltham, Mass.

This daylong program is designed to give RA, QA and C-level executives a one-day crash course on the pending regulatory issues facing the industry. The agenda will include comprehensive presentations by FDA officials, industry representatives and regulatory experts. Complete information will be available later this fall.

Register here.

Sponsored by: